WallStSmart

Brookfield Corp (BN)vsCrescent Capital BDC Inc (CCAP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Brookfield Corp generates 48415% more annual revenue ($79.11B vs $163.07M). CCAP leads profitability with a 9.3% profit margin vs 1.7%. CCAP appears more attractively valued with a PEG of 0.89. BN earns a higher WallStSmart Score of 63/100 (C+).

BN

Buy

63

out of 100

Grade: C+

Growth: 6.0Profit: 5.5Value: 4.3Quality: 4.0
Piotroski: 5/9Altman Z: 0.64

CCAP

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 6.5Value: 6.3Quality: 4.3
Piotroski: 5/9Altman Z: 0.58

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BN4 strengths · Avg: 8.8/10
EPS GrowthGrowth
158.8%10/10

Earnings expanding 158.8% YoY

Market CapQuality
$101.83B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
28.9%8/10

Strong operational efficiency at 28.9%

CCAP3 strengths · Avg: 9.3/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Operating MarginProfitability
78.6%10/10

Strong operational efficiency at 78.6%

PEG RatioValuation
0.898/10

Growing faster than its price suggests

Areas to Watch

BN4 concerns · Avg: 2.5/10
Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
1.7%3/10

1.7% margin — thin

P/E RatioValuation
89.4x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-5.60B2/10

Negative free cash flow — burning cash

CCAP4 concerns · Avg: 3.3/10
P/E RatioValuation
28.8x4/10

Moderate valuation

Market CapQuality
$424.10M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Debt/EquityHealth
1.353/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : BN

The strongest argument for BN centers on EPS Growth, Market Cap, Price/Book. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bull Case : CCAP

The strongest argument for CCAP centers on Price/Book, Operating Margin, PEG Ratio. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bear Case : BN

The primary concerns for BN are Return on Equity, Profit Margin, P/E Ratio. A P/E of 89.4x leaves little room for execution misses. Debt-to-equity of 5.72 is elevated, increasing financial risk.

Bear Case : CCAP

The primary concerns for CCAP are P/E Ratio, Market Cap, Return on Equity.

Key Dynamics to Monitor

BN carries more volatility with a beta of 1.85 — expect wider price swings.

BN is growing revenue faster at 7.9% — sustainability is the question.

CCAP generates stronger free cash flow (-24M), providing more financial flexibility.

Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BN scores higher overall (63/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Brookfield Corp

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. The company is headquartered in Toronto, Canada with additional offices across Northern America; South America; Europe; Middle East and Asia.

Crescent Capital BDC Inc

FINANCIAL SERVICES · ASSET MANAGEMENT · USA

Crescent Capital BDC, Inc. is a business development company. The company is headquartered in United States.

Visit Website →

Want to dig deeper into these stocks?